Southern Medical Therapies - Biological


The advances in molecular biology over the last twenty years has revolutionized the health care industry and medical science. With the approval of human insulin in 1982, the pharmaceutical industry now has more than 100 biotechnology medications available or in development. Colony stimulating factors such as erythropoietin (EPO, Epogen, Procrit) and filgrastin (Neupogen) are injectables frequently administered long-term. Alpha-1 Antitrypsin (Prolastin) therapy can be administered safely in the home. Treatment care plans and protocols can be developed and individualized to your patient's needs.

Many biologicals are expensive. Our reimbursement specialists will investigate and identify all potential possibilities of coverage.



1999 Southern Medical Inc.